| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Innoviva Inc (NASDAQ: INVA)
INVA Technical Analysis
5
| As on 9th Jun 2023 INVA STOCK Price closed @ 13.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.57 & Strong Sell for SHORT-TERM with Stoploss of 17.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INVASTOCK Price
| Open | 13.69 | Change | Price | % |
| High | 13.69 | 1 Day | -0.42 | -3.06 |
| Low | 13.28 | 1 Week | -0.19 | -1.41 |
| Close | 13.30 | 1 Month | 1.42 | 11.95 |
| Volume | 487400 | 1 Year | -3.70 | -21.76 |
| 52 Week High 20.25 | 52 Week Low 10.73 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| INVA Daily Charts |
INVA Intraday Charts |
Whats New @ Bazaartrend |
INVA Free Analysis |
|
|
INVA Important Levels Intraday
| RESISTANCE | 14.09 |
| RESISTANCE | 13.84 |
| RESISTANCE | 13.68 |
| RESISTANCE | 13.52 |
| SUPPORT | 13.08 |
| SUPPORT | 12.92 |
| SUPPORT | 12.76 |
| SUPPORT | 12.51 |
INVA Forecast May 2024
| 4th UP Forecast | 23.71 |
| 3rd UP Forecast | 20.37 |
| 2nd UP Forecast | 18.31 |
| 1st UP Forecast | 16.24 |
| 1st DOWN Forecast | 10.36 |
| 2nd DOWN Forecast | 8.29 |
| 3rd DOWN Forecast | 6.23 |
| 4th DOWN Forecast | 2.89 |
INVA Weekly Forecast
| 4th UP Forecast | 14.80 |
| 3rd UP Forecast | 14.32 |
| 2nd UP Forecast | 14.02 |
| 1st UP Forecast | 13.73 |
| 1st DOWN Forecast | 12.87 |
| 2nd DOWN Forecast | 12.58 |
| 3rd DOWN Forecast | 12.28 |
| 4th DOWN Forecast | 11.80 |
INVA Forecast2024
| 4th UP Forecast | 32.7 |
| 3rd UP Forecast | 26.48 |
| 2nd UP Forecast | 22.63 |
| 1st UP Forecast | 18.79 |
| 1st DOWN Forecast | 7.81 |
| 2nd DOWN Forecast | 3.97 |
| 3rd DOWN Forecast | 0.12 |
| 4th DOWN Forecast | -6.1 |
Innoviva Inc ( NASDAQ USA Symbol : INVA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INVA Business Profile
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California. Address: 1350 Old Bayshore Highway, Burlingame, CA, United States, 94010
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service